A cross-sectional pilot study of blood utilization in 27 hospitals in Northern California

American Journal of Clinical Pathology

Volumn 142, Issue 4, 2014, Pages 498-505

  Bloch, Evan M ^a,b   Cohn, Claudia ^b,c   Bruhn, Roberta ^a   Hirschler, Nora ^b   Nguyen, Kim Anh ^b,d  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b Blood Centers of the Pacific   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d Blood Bank of Hawaii   (United States)

Author keywords

Blood transfusions; Quality management; Utilization

Indexed keywords

ARTICLE; BLOOD; BLOOD COMPONENT; BLOOD TRANSFUSION; CROSS-SECTIONAL STUDY; CRYOPRECIPITATE; ERYTHROCYTE; HEALTH CARE FACILITY; HEALTH CARE SURVEY; HOSPITAL; HOSPITAL UTILIZATION; HUMAN; INFORMATION SYSTEM; MEDICAL PRACTICE; PILOT STUDY; PLASMA; PRIORITY JOURNAL; QUALITY CONTROL; THROMBOCYTE; UNITED STATES; BLOOD BANK; BLOOD COMPONENT THERAPY; BLOOD GROUP TYPING; EPIDEMIOLOGY; INFORMATION PROCESSING; PROCEDURES; STANDARDS; STATISTICS AND NUMERICAL DATA; UTILIZATION;

BLOOD BANKS; BLOOD COMPONENT TRANSFUSION; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; CALIFORNIA; CROSS-SECTIONAL STUDIES; DATA COLLECTION; HOSPITALS; HUMANS; PILOT PROJECTS;

EID: 84921657436     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP8WFIQ0JRCSIR     Document Type: Article

References (40)

1. Best Practices for a Patient Blood Management Program. Bethesda, MD: AABB; 2012.
2. Cohn CS, Welbig J, Bowman R, et al. A data-driven approach to patient blood management. Transfusion. 2014;54:316-322.
3. Perkins HA, Busch MP. Transfusion-associated infections: 50 years of relentless challenges and remarkable progress. Transfusion. 2010;50:2080-2099.
4. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev. 2007;21:327-348.
5. Hendrickson JE, Hillyer CD. Noninfectious serious hazards of transfusion. Anesth Analg. 2009;108:759-769.
6. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409-417.
7. Lacroix J, Hebert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007;356:1609-1619.
8. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2012;4:CD002042.
9. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011;365:2453-2462.
10. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368:11-21.
11. Goodnough LT, Shander A. Patient blood management. Anesthesiology. 2012;116:1367-1376.
12. Goodnough LT. Blood management: transfusion medicine comes of age. Lancet. 2013;381:1791-1792.
13. Goodnough LT, Shander A. Blood management. Arch Pathol Lab Med. 2007;131:695-701.
14. Roback JD. Technical Manual. Bethesda, MD: AABB Press; 2008:525-543.
15. Stainsby D, Jones H, Asher D, et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev. 2006;20:273-282.
16. Hogshire L, Carson JL. Red blood cell transfusion: what is the evidence when to transfuse? Curr Opin Hematol. 2013;20:546-551.
17. Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2012;157:49-58.
18. Slichter SJ. Relationship between platelet count and bleeding risk in thrombocytopenic patients. Transfus Med Rev. 2004;18:153-167.
19. Gaydos LA, Freireich EJ, Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med. 1962;266:905-909.
20. Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med. 1997;337:1870-1875.
21. Heddle NM, Cook RJ, Sigouin C, et al. A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia. Transfusion. 2006;46:903-911.
22. 9 per L in allogeneic hematopoietic progenitor cell transplant recipients. Transfusion. 2005;45:1064-1072.
23. 9/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood. 1998;91:3601-3606.
24. Holland LL, Foster TM, Marlar RA, et al. Fresh frozen plasma is ineffective for correcting minimally elevated international normalized ratios. Transfusion. 2005;45:1234-1235.
25. Wallis J P, Dzik S. Is fresh frozen plasma overtransfused in the United States? Transfusion. 2004;44:1674-1675.
26. Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion. 2006;46:1279-1285.
27. Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2012. Silver Spring, MD: US Food and Drug Administration; 2013.
28. Makar RS, Powers A, Stowell C P. Reducing transfusion-related acute lung injury risk: evidence for and approaches to transfusion-related acute lung injury mitigation. Transfus Med Rev. 2012;26:305-320.
29. Rios JA, Schlumpf KS, Kakaiya RM, et al. Blood donations from previously transfused or pregnant donors: a multicenter study to determine the frequency of alloexposure. Transfusion. 2011;51:1197-1206.
30. Chapman JF, Milkins C, Voak D. The computer crossmatch: a safe alternative to the serological crossmatch. Transfus Med. 2000;10:251-256.
31. Richardson NG, Bradley WN, Donaldson DR, et al. Maximum surgical blood ordering schedule in a district general hospital saves money and resources. Ann R Coll Surg Engl. 1998;80:262-265.
32. Cheng G. Experiences with "self service" electronic blood banking. Vox Sang. 1998;74(suppl 2):427-429.
33. Shaz BH, Dente CJ, Harris RS, et al. Transfusion management of trauma patients. Anesth Analg. 2009;108:1760-1768.
34. Dente CJ, Shaz BH, Nicholas JM, et al. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma. 2009;66:1616-1624.
35. Bowden RA, Slichter SJ, Sayers MH, et al. Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant. Blood. 1991;78:246-250.
36. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood. 1995;86:3598-3603.
37. Whiting D, Dinardo JA. TEG and ROTEM: technology and clinical applications. Am J Hematol. 2014;89:228-232.
38. Avidan MS, Alcock EL, Da Fonseca J, et al. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth. 2004;92:178-186.
39. Ak K, Isbir CS, Tetik S, et al. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study. J Card Surg. 2009;24:404-410.
40. Afshari A, Wikkelso A, Brok J, et al. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev. 2011;(3):CD007871.